Finch Therapeutics Group, Inc. - FNCH

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2024 · Q4 2023
Value (USD)
Total reported value ($000)
$259K
QoQ value delta ($000)
-$144K (-35.73%)
Implied price effect (QoQ)
-27.53%
Shares
Total shares
99,743
QoQ shares delta
-12,732 (-11.32%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (FNCH)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2024)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP 155 59,028 0.0%
VANGUARD GROUP INC 94 36,252 0.0%
Tower Research Capital LLC (TRC) 10 4,163 0.0%
WELLS FARGO & COMPANY/MN 0 7 0.0%
MORGAN STANLEY 0 156 0.0%
ROYAL BANK OF CANADA 0 27 0.0%
UBS Group AG 0 110 0.0%